Spoken Alpha
NBP
NovaBridge Biosciences
Overview
NovaBridge Biosciences is a Healthcare company operating in Biotechnology with a $185.6M market cap.
Most recent earnings call: Q2 FY24 on Aug 28, 2024.
5 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks NBP's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2024 | $5.25 | $4.16 | +26.2% | -1.7% | -2.2% |
| Q4 FY2024 | $5.51 | $4.09 | +34.8% | +6.5% | +4.9% |
| Q3 FY2024 | $5.27 | $4.12 | +28.0% | +0.9% | -1.1% |
| Q2 FY2024 | $5.72 | $4.19 | +36.4% | +3.7% | +4.6% |
| Q1 FY2023 | $5.35 | $4.17 | +28.4% | +5.3% | +6.5% |
| Q4 FY2023 | $5.61 | $4.28 | +31.1% | +5.9% | +7.4% |
| Q3 FY2023 | $5.76 | $4.23 | +36.2% | +7.3% | +8.9% |
| Q2 FY2023 | $5.70 | $4.24 | +34.5% | -2.8% | -0.6% |
| Q1 FY2022 | $5.57 | $4.17 | +33.6% | -0.3% | +1.8% |
| Q4 FY2022 | $6.14 | $4.35 | +41.2% | +2.8% | +2.6% |
Guidance change history
Sample- Q1 FY2024Raised2024-04-15
- Q4 FY2024Raised2024-13-15
- Q3 FY2024Raised2024-10-15
- Q2 FY2024Raised2024-07-15
- Q1 FY2023Raised2023-04-15
- Q4 FY2023Raised2023-13-15
- Q3 FY2023Raised2023-10-15
- Q2 FY2023Raised2023-07-15
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NBP.
$ curl https://api.spokenalpha.com/v1/companies/NBPFAQ
Frequently asked about NBP
Where can I find NovaBridge Biosciences's (NBP) earnings call transcripts?
Spoken Alpha indexes NBP's earnings call transcripts at https://spokenalpha.com/companies/NBP. Each call links to attributed speakers and parsed analyst Q&A.
When was NovaBridge Biosciences's most recent earnings call?
NovaBridge Biosciences (NBP) held its most recent earnings call on 2024-08-28, covering fiscal Q2 2024.
What sector is NBP in?
NovaBridge Biosciences (NBP) operates in the Healthcare sector (Biotechnology industry).